Matthew D. Perry Profile

Teksia develops memorable events, technology forums and exhibitions through extensive databank of international high-tech communities around the world.

Teksia creates the environment for successful information exchange by linking different communities and their peers to business prospects in the U.S. and international markets.

June 24 - 25

ITF 2009

Stanford University, CA


General Information


Name:	Matthew D. Perry
Company:	Biotechnology Value Fund, L.P.
Title:
Profile:	Matthew Perry is the Portfolio Manager of the Biotechnology Value Fund, L.P. (BVF). BVF is a private investment fund that manages approximately $600m. The fund focuses on small-cap, value oriented investment opportunities. Mr. Perry joined Biotechnology Value Fund, L.P. in December 1996 as an investment analyst. Prior to joining BVF, Mr. Perry held the position of account executive with Feinstein Partners; a consulting firm with an emphasis on investor relations for emerging health care companies focused on the development and commercialization of therapeutic products. He was simultaneously an account executive with FPI’s affiliate, Kendall Strategies, a business development and strategy consulting firm assisting start-up through large public biotechnology and pharmaceutical companies. Before joining Feinstein Partners/Kendall Strategies, Mr. Perry owned and operated a private business for two years and monitored the biotechnology sector through an active investment program. Mr. Perry is also a co-founder and director of Nordic Biotech Advisors ApS, a venture capital firm based in Copenhagen, Denmark. He holds a B.S. degree from the Biology Department at the College of William and Mary.

About ITF | Upcoming Event | Agenda | Speakers | Sponsorship